| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |